Jason Patrick Meyenburg

Insider Reports History

Reporting-owner location: Rockville, MD
Latest reporting-owner signature: /s/ Brian Piekos, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jason Patrick Meyenburg

Form 4 holding Chief Executive Officer, Director

Gemini Therapeutics, Inc. /DE

Security class: Restricted Stock Units
Shares / value: 123,600
Estimated value
Report date: 03 Jan 2022
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Jason Patrick Meyenburg

4 IRON

Gemini Therapeutics, Inc. /DE

Report period: 03 Jan 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jan 2022, 15:08
Role: Chief Executive Officer, Director
Next action: Open filing details

4 IRON

Gemini Therapeutics, Inc. /DE

Report period: 14 May 2021
Transactions: 1
Transaction value: +$122,929
Accepted by SEC: 18 May 2021, 16:45
Role: President & CEO, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .